These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Barbour GL; Straub KD; O'Neal BL; Leatherman JW Arch Intern Med; 1979 Jan; 139(1):86-8. PubMed ID: 760689 [TBL] [Abstract][Full Text] [Related]
3. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration. Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972 [TBL] [Abstract][Full Text] [Related]
8. Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis. Rapoport J; Chaimovitz C; Alroy GG; Better OS Isr J Med Sci; 1979 Sep; 15(9):765-71. PubMed ID: 41818 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of urinary concentration in nephrogenic diabetes insipidus. McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007 [TBL] [Abstract][Full Text] [Related]
10. Nephrogenic diabetes insipidus in a dog with renal medullary lesions. Joles JA; Gruys E J Am Vet Med Assoc; 1979 Apr; 174(8):830-4. PubMed ID: 500424 [TBL] [Abstract][Full Text] [Related]
11. Nephrogenic diabetes insipidus and lithium intoxication--complications of lithium carbonate therapy. Lee RV; Jampol LM; Brown WV N Engl J Med; 1971 Jan; 284(2):93-4. PubMed ID: 5538641 [No Abstract] [Full Text] [Related]
12. A heterologous radioimmunoassay for arginine vasopressin. Shimamoto K; Murase T; Yamaji T J Lab Clin Med; 1976 Feb; 87(2):338-44. PubMed ID: 1245796 [TBL] [Abstract][Full Text] [Related]
13. Lithium and the kidney. MacDonald KJ; Little PJ; Bailey RR N Z Med J; 1979 Oct; 90(646):323-5. PubMed ID: 293541 [TBL] [Abstract][Full Text] [Related]
14. [Plasma values of arginine vasopressin in patients treated with lithium carbonate]. Lucas A; Sanmartí A; Catalán R; Galard R; Castellanos JM; Martínez-Pina A; Foz M Med Clin (Barc); 1984 Sep; 83(7):276-9. PubMed ID: 6436592 [No Abstract] [Full Text] [Related]
15. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate. Weinstock RS; Moses AM South Med J; 1990 Dec; 83(12):1475-7. PubMed ID: 2123565 [TBL] [Abstract][Full Text] [Related]
16. Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass. Leeman MF; Vuylsteke A; Ritchie AJ Ann Thorac Surg; 2007 Aug; 84(2):656-7. PubMed ID: 17643658 [TBL] [Abstract][Full Text] [Related]
19. [A case of congenital nephrogenic diabetes insipidus accompanied by hypertension]. Minami J; On K; Inada H; Ono H; Ishimitsu T; Matsuoka H Nihon Jinzo Gakkai Shi; 2001; 43(1):35-8. PubMed ID: 11218316 [TBL] [Abstract][Full Text] [Related]
20. Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria. Christensen S; Geisler A Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):447-54. PubMed ID: 190861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]